Irish Cannabis Patients Will Now Gain Access To New Products Through This International Agreement

SOMAÍ Pharmaceuticals has partnered with Georgelle Pharmaceutical Ltd. to bring an extensive range of cannabis-based medicines to Irish patients.

This marks SOMAÍ’s fifth international expansion, having already established operations in the UK, Australia, Germany, and Poland earlier this year.

Under a three-year agreement, SOMAÍ will supply Irish cannabis-prescribing clinics with a diverse cannabinoid-containing product line, including THC, CBD, and balanced oral solutions.

Read Also: Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound

The range will later expand to …

Full story available on Benzinga.com